OpenURL Connection Search

Select item for more details and to access through your institution.

Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study.
Published in:
Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 975, doi. 10.1007/s00432-021-03693-5
By:
- Leclerc, V.;
- Karlin, L.;
- Herledan, C.;
- Marchal, L.;
- Baudouin, A.;
- Gouraud, A.;
- Caffin, A. G.;
- Larbre, V.;
- Lazareth, A.;
- Bachy, E.;
- Salles, G.;
- Ghesquières, H.;
- Rioufol, C.;
- Ranchon, F.
Publication type:
Article
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.
Published in:
European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 9, p. 2033, doi. 10.1007/s10096-021-04186-6
By:
- Soueges, Sarah;
- Triffault-Fillit, Claire;
- Roux, Sandrine;
- Labussière-Wallet, Hélène;
- Lebeaux, David;
- Dumitrescu, Oana;
- Morelec, Isabelle;
- Hodille, Elisabeth;
- Ader, Florence;
- On behalf of the Lyon HEMINF study group;
- Ader, F.;
- Alcazer, V.;
- Bachy, E.;
- Balsat, M.;
- Barraco, F.;
- Boccard, M.;
- Conrad, A.;
- Ducastelle-Leprêtre, S.;
- Dumitrescu, O.;
- Dupont, D.
Publication type:
Article
Sarcoidosis and lymphoma: a comparative study.
Published in:
QJM: An International Journal of Medicine, 2015, v. 108, n. 11, p. 871, doi. 10.1093/qjmed/hcv039
By:
- CHALAYER, É.;
- BACHY, E.;
- OCCELLI, P.;
- WEILER, L.;
- FAURIE, P.;
- GHESQUIERES, H.;
- PAVIC, M.;
- BROUSSOLLE, C.;
- SÈVE, P.
Publication type:
Article
TRIAL IN PROGRESS: ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, FOR THE TREATMENT OF RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL)—A COHORT FROM THE ELM‐2 STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 846, doi. 10.1002/hon.3166_OT25
By:
- Cho, S.;
- Kim, T. M.;
- Taszner, M.;
- Chen, T. Y.;
- Chaudhry, A.;
- Ufkin, M.;
- Uppala, A.;
- Sabir, A.;
- Mohamed, H.;
- Ambati, S.;
- Bachy, E.
Publication type:
Article
KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 838, doi. 10.1002/hon.3166_OT18
By:
- Cheminant, M.;
- Carras, S.;
- Bruneau, J.;
- Lemonnier, F.;
- Bachy, E.;
- Herbaux, C.;
- Feugier, P.;
- Daguindau, N.;
- Gastinne, T.;
- Guillermin, Y.;
- Lamarque, M.;
- Slama, B.;
- Wolfromm, A.;
- Morschhauser, F.;
- Tournilhac, O.;
- Gaulard, P.;
- Asnafi, V.;
- Ortonne, N.;
- Damaj, G.;
- Hermine, O.
Publication type:
Article
AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 147, doi. 10.1002/hon.3163_97
By:
- Houot, R.;
- Bachy, E.;
- Cartron, G.;
- Gros, F.;
- Morschhauser, F.;
- Oberic, L.;
- Gastinne, T.;
- Feugier, P.;
- Dulery, R.;
- Thieblemont, C.;
- Joris, M.;
- Jardin, F.;
- Choquet, S.;
- Casasnovas, O.;
- Brisou, G.;
- Cheminant, M.;
- Bay, J.;
- Gutierrez, F. Llamas;
- Menard, C.;
- Tarte, K.
Publication type:
Article
NATHALI‐01: A PHASE 1/2A TRIAL OF UCART20X22, AN ALLOGENEIC DUAL CAR T‐CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2023, v. 41, p. 825, doi. 10.1002/hon.3166_OT08
By:
- Bachy, E.;
- Ramakrishnan, A.;
- Thieblemont, C.;
- Alfonso, A.;
- Braunschweig, I.;
- Riedell, P. A.;
- Cartron, G.;
- Barba, P.;
- Gastinne, T.;
- Simon, J. A. Perez;
- Solano, C.;
- Meadows, S.;
- LaCroce, A.;
- Thomas, D.;
- Poirot, C.;
- Newhall, K. J.;
- Lee, D. J.;
- Frattini, M. G.;
- Abramson, J.
Publication type:
Article
GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 144, doi. 10.1002/hon.3163_95
By:
- Dickinson, M.;
- Carlo‐Stella, C.;
- Morschhauser, F.;
- Falchi, L.;
- Bachy, E.;
- Cartron, G.;
- Khan, C.;
- Tani, M.;
- Martinez‐Lopez, J.;
- Bartlett, N.;
- Salar, A.;
- Brody, J.;
- Leppä, S.;
- Mulvihill, E.;
- Lundberg, L.;
- Relf, J.;
- Xie, Y.;
- Bottos, A.;
- Humphrey, K.;
- Hutchings, M.
Publication type:
Article
OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2023, v. 41, p. 134, doi. 10.1002/hon.3163_90
By:
- Michot, J. M.;
- Chavez, J.;
- Carpio, C.;
- Bachy, E.;
- Ferrari, S.;
- Morschhauser, F.;
- Jørgensen, J. M.;
- Cordoba, R.;
- Bories, P.;
- Patah, P.;
- de Moucheron, B.;
- Carrancio, S.;
- Guarinos, C.;
- Zheng, X.;
- Mei, C.;
- Pourdehnad, M.;
- Nastoupil, L.
Publication type:
Article
PHASE 1 STUDY OF JNJ‐67856633, A FIRST‐IN‐HUMAN MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).
Published in:
Hematological Oncology, 2023, v. 41, p. 131, doi. 10.1002/hon.3163_88
By:
- Hertzberg, M.;
- Kalac, M.;
- Cheah, C. Y.;
- Ribrag, V.;
- Abrisqueta, P.;
- Opat, S.;
- Bachy, E.;
- Ysebaert, L.;
- Qiu, L.;
- Yi, S.;
- Nishimura, N.;
- Lemech, C.;
- Bussolari, J.;
- Deng, C.;
- Lu, T.;
- Xiu, L.;
- Hemelryck, S. V.;
- Philippar, U.;
- Guo, Y.;
- Soete, V.
Publication type:
Article
ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2.
Published in:
Hematological Oncology, 2023, v. 41, p. 121, doi. 10.1002/hon.3163_82
By:
- Novelli, S.;
- Luminari, S.;
- Taszner, M.;
- Cho, S.;
- Le Gouill, S.;
- Poon, M.;
- Villasboas, J. C.;
- Champion, R.;
- Bachy, E.;
- Guidez, S.;
- Alonso, A.;
- Jagadeesh, D.;
- Merli, M.;
- Tucker, D.;
- Cai, J.;
- Leite de Oliveira, C.;
- Zhu, M.;
- Chaudhry, A.;
- Mohamed, H.;
- Ambati, S.
Publication type:
Article
CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HELPER T‐CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 108, doi. 10.1002/hon.3163_69
By:
- Loyaux, R.;
- Sako, N.;
- Quang, V. Tran;
- Bachy, E.;
- Morschhauser, F.;
- Cartron, G.;
- Gressin, R.;
- Daguindau, N.;
- Le Gouill, S.;
- Wolfromm, A.;
- Bouabdallah, K.;
- Ysebaert, L.;
- Casasnovas, O.;
- Robe, C.;
- Delfau, M.;
- Dupuis, J.;
- De Leval, L.;
- Gaulard, P.;
- Sloma, I.;
- Lemonnier, F.
Publication type:
Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 94, doi. 10.1002/hon.3163_58
By:
- Rebaud, L.;
- Capobianco, N.;
- Spottiswoode, B.;
- Cottereau, A.;
- Trotman, J.;
- Feugier, P.;
- Nastoupil, L. J.;
- Bachy, E.;
- Flinn, I. W.;
- Haioun, C.;
- Ysebaert, L.;
- Bartlett, N. L.;
- Tilly, H.;
- Casasnovas, R.;
- Ricci, R.;
- Portugues, C.;
- Meignan, M.;
- Morschhauser, F.;
- Buvat, I.
Publication type:
Article
Functional precision oncology for follicular lymphoma with patient‐derived xenograft in avian embryos.
Published in:
Hematological Oncology, 2023, v. 41, p. 549, doi. 10.1002/hon.3164_410
By:
- Zala, M.;
- Lipinski, B.;
- Costechareyre, C.;
- Jarrosson, L.;
- Teinturier, R.;
- Julia, E.;
- Verney, A.;
- Guitton, J.;
- Traverse‐Glehen, A.;
- Bachy, E.;
- Salles, G.;
- Huet, S.;
- Genestier, L.;
- Castellani, V.;
- Delloye‐Bourgeois, C.;
- Sujobert, P.
Publication type:
Article
Transfusion needs after CD19 CAR T‐cells for large B‐cell lymphoma: predictive factors and impact on outcome. A DESCAR‐T study.
Published in:
Hematological Oncology, 2023, v. 41, p. 534, doi. 10.1002/hon.3164_397
By:
- Vic, S.;
- Thibert, J.;
- Bachy, E.;
- Cartron, G.;
- Gastinne, T.;
- Morschhauser, F.;
- Le Bras, F.;
- Bouabdallah, K.;
- Despas, F.;
- Bay, J.;
- Rubio, M.;
- Mohty, M.;
- Casasnovas, O.;
- Choquet, S.;
- Castilla‐Llorente, C.;
- Guidez, S.;
- Loschi, M.;
- Guffroy, B.;
- Carras, S.;
- La Rochelle, L. Drieu
Publication type:
Article
Long‐term efficacy and safety of zanubrutinib (ZANU) in relapsed/refractory marginal zone lymphoma (R/R MZL): final analysis of the MAGNOLIA (BGB‐3111‐214) trial.
Published in:
Hematological Oncology, 2023, v. 41, p. 390, doi. 10.1002/hon.3164_284
By:
- Trotman, J.;
- Tedeschi, A.;
- Hu, B.;
- Linton, K. M.;
- McKay, P.;
- Leitch, S.;
- Jin, J.;
- Sun, M.;
- Sobieraj‐Teague, M.;
- Zinzani, P. L.;
- Browett, P.;
- Thieblemont, C.;
- Liberati, A. M.;
- Bachy, E.;
- Cavallo, F.;
- Costello, R.;
- Iyengar, S.;
- Marasca, R.;
- Mociková, H.;
- Kim, J. S.
Publication type:
Article
Cell‐free DNA sequencing allows the identification of the mutational profile of TFH lymphomas and has a predictive value: a LYSA study.
Published in:
Hematological Oncology, 2023, v. 41, p. 338, doi. 10.1002/hon.3164_241
By:
- Sako, N.;
- Delfau, M.;
- Bachy, E.;
- Morschhauser, F.;
- Cartron, G.;
- Casasnovas, O.;
- Gressin, R.;
- Daguindau, N.;
- Tournilhac, O.;
- Bouabdallah, K.;
- Le Gouill, S.;
- Andre, M.;
- Robe, C.;
- Dupuis, J.;
- De Leval, L.;
- Gaulard, P.;
- Lemonnier, F.
Publication type:
Article
A low lymphocyte‐to‐monocyte ratio (LMR) predicts PFS, POD24 and OS in previously untreated, high tumor burden follicular lymphoma (FL): an analysis from the RELEVANCE trial.
Published in:
Hematological Oncology, 2023, v. 41, p. 290, doi. 10.1002/hon.3164_200
By:
- Mozas, P.;
- Ammar, R. Ould;
- Chartier, L.;
- Nastoupil, L.;
- Bachy, E.;
- Bezsera, S. M.;
- Barnes, J.;
- Bijou, F.;
- Goy, A.;
- Zerazhi, H.;
- Cartron, G.;
- Ojeda‐Uribe, M.;
- Choquet, S.;
- Joly, B.;
- Cheminant, M.;
- García‐Sancho, A. Martín;
- Eradat, H.;
- Gressin, R.;
- Abrisqueta, P.;
- Parcelier, A.
Publication type:
Article
EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA : RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 179, doi. 10.1002/hon.3163_113
By:
- Delfau‐Larue, M.;
- Viailly, P.;
- Cartron, G.;
- Morschhauser, F.;
- Gros, F.;
- Gastinne, T.;
- Oberic, L.;
- Bachy, E.;
- Dulery, R.;
- Feugier, P.;
- Menard, C.;
- Quelen, C.;
- Pangault, C.;
- Portugues, C.;
- Gomes, L.;
- Itti, E.;
- Bailly, C.;
- Lemonnier, F.;
- Laurent, C.;
- Houot, R.
Publication type:
Article
A PHASE 1, MULTICENTER, OPEN‐LABEL STUDY OF CC‐99282 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.89_2881
By:
- Michot, J.‐M.;
- Carpio, C.;
- Nastoupil, L.;
- Chavez, J.;
- Feldman, T.;
- Ferrari, S.;
- Morillo, D.;
- Bachy, E.;
- Pinto, A.;
- Kuruvilla, J.;
- Buchholz, T. J.;
- Kasibhatla, S.;
- Carrancio, S.;
- Guarinos, C.;
- Wu, F.;
- Li, S.;
- Patah, P.;
- Pourdehnad, M.
Publication type:
Article
EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.85_2879
By:
- Schuster, S. J.;
- Dickinson, M.;
- Dreyling, M.;
- Martinez‐Lopez, J.;
- Kolstad, A.;
- Butler, J.;
- Ghosh, M.;
- Popplewell, L.;
- Chavez, J. C.;
- Bachy, E.;
- Kato, K.;
- Harigae, H.;
- Kersten, M. José;
- Andreadis, C.;
- Riedell, P. A.;
- Abdelhady, A.;
- Zia, A.;
- Morisse, M. C.;
- Fowler, N. H.;
- Thieblemont, C.
Publication type:
Article
FIRST RESULTS OF DLBCL PATIENTS TREATED WITH CAR‐T CELLS AND ENROLLED IN DESCAR‐T REGISTRY, A FRENCH REAL‐LIFE DATABASE FOR CAR‐T CELLS IN HEMATOLOGIC MALIGNANCIES.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.84_2879
By:
- Le Gouill, S.;
- Bachy, E.;
- Di Blasi, R.;
- Cartron, G.;
- Beauvais, D.;
- Le Bras, F.;
- Gros, François‐X.;
- Choquet, S.;
- Bories, P.;
- Rubio, Marie‐Thérès.;
- Casasnovas, René‐O.;
- Bounaix, L.;
- Mohty, M.;
- Joris, M.;
- Gastinne, T.;
- Sesques, P.;
- Tudesq, J. J.;
- Morschhauser, F.;
- Gat, E.;
- Broussais, F.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.57_2880
By:
- Herbaux, C.;
- Schiano de Colella, J. M.;
- Thieblemont, C.;
- Guidez, S.;
- Ysebaert, L.;
- Tilly, H.;
- Le Gouill, S.;
- Houot, R.;
- Bachy, E.;
- Laurent, C.;
- Damaj, G.;
- Feugier, P.;
- Morineau, N.;
- Tarte, K.;
- Morschhauser, F.;
- Cartron, G.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
By:
- Cartron, G.;
- Bachy, E.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Sibon, D.;
- Casasnovas, O.;
- Le Gouill, S.;
- Tilly, H.;
- Ysebaert, L.;
- Schiano de Colella, J. M.;
- Feugier, P.;
- Virelizier, E. Nicolas;
- Haioun, C.;
- Damaj, G.;
- Tarte, K.;
- Laurent, C.;
- Houot, R.;
- Thieblemont, C.
Publication type:
Article
SAFETY AND EFFICACY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA PHASE 2 STUDY)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.19_2880
By:
- Trotman, J.;
- Tedeschi, A.;
- Linton, K.;
- McKay, P.;
- Hu, B.;
- Chan, H.;
- Jin, J.;
- Sobieraj‐Teague, M.;
- Zinzani, P. L.;
- Coleman, M.;
- Browett, P.;
- Ke, X.;
- Sun, M.;
- Marcus, R.;
- Portell, C.;
- Thieblemont, C.;
- Zhou, K.;
- Liberati, A. M.;
- Bachy, E.;
- Cavallo, F.
Publication type:
Article
PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.178_2880
By:
- Fowler, N. H.;
- Dickinson, M.;
- Martinez‐Lopez, J.;
- Kolstad, A.;
- Schuster, S. J.;
- Dreyling, M.;
- Ghosh, M.;
- Harigae, H.;
- Kersten, M. José;
- Bachy, E.;
- Popplewell, L.;
- Chavez, J. C.;
- Ho, P. J.;
- Butler, J.;
- Kato, K.;
- von Tresckow, B.;
- Ferreri, A. J. M.;
- Simón, J. A. P.;
- Patten, P. E. M.;
- Andreadis, C.
Publication type:
Article
GLOFITAMAB STEP‐UP DOSING: UPDATED EFFICACY DATA SHOW HIGH COMPLETE RESPONSE RATES IN HEAVILY PRETREATED RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL) PATIENTS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.15_2879
By:
- Carlo‐Stella, C;
- Hutchings, M;
- Offner, F. C;
- Morschhauser, F;
- Bachy, E;
- Crump, M;
- Sureda, A;
- Iacoboni, G;
- Haioun, C;
- Perez‐Callejo, D;
- Lundberg, L;
- Relf, J;
- Clark, E;
- Carlile, D;
- Piccione, E;
- Belousov, A;
- Humphrey, K;
- Dickinson, M. J
Publication type:
Article
PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULATORY THERAPY CRITERIA (LYRIC) IN GATA TRIAL FROM THE LYSA GROUP.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.157_2880
By:
- Al Tabaa, Y.;
- Casasnovas, O.;
- Baillet, C.;
- Bachy, E.;
- Virelizier, E. Nicolas;
- Schiano de Colella, J. M.;
- Bailly, C.;
- Kanoun, S.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Ysebaert, L.;
- Le Gouill, S.;
- Tilly, H.;
- Houot, R.;
- Morschhauser, F.;
- Cartron, G.;
- Herbaux, C.
Publication type:
Article
CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON‐HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.150_2880
By:
- Depaus, J;
- Wagner‐Johnston, N;
- Zinzani, P. L;
- Phillips, T. J;
- Maly, J;
- Ferrari, S;
- Bachy, E;
- Bryan, L. J;
- Delwail, V;
- Janakiram, M;
- de Guibert, S;
- Tani, M;
- Dai, V;
- Havenith, K;
- Boni, J;
- He, X;
- Ervin‐Haynes, A;
- Carlo‐Stella, C
Publication type:
Article
IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.137_2880
By:
- Sibon, D;
- Bisig, B;
- Bonnet, C;
- Bachy, E;
- Cavalieri, D;
- Fataccioli, V;
- Drieux, F;
- Bruneau, J;
- Lemonnier, F;
- Bossard, C;
- Bouabdallah, K;
- Parrens, M;
- Damaj, G;
- Tournilhac, O;
- Jais, J. P;
- Gaulard, P;
- de Leval, L
Publication type:
Article
BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 278, doi. 10.1002/hon.89_2630
By:
- Lemonnier, F.;
- Safar, V.;
- Ferchiou, A.;
- Cottereau, A.;
- Bachy, E.;
- Cartron, G.;
- Moles‐Moreau, M.;
- Delmer, A.;
- Bouabdallah, R.;
- Voillat, L.;
- Parrens, M.;
- Casasnovas, O.;
- Cacheux, V.;
- Réguy, C.;
- Tilly, H.;
- Meignan, M.;
- Gaulard, P.;
- Leval, L.;
- Delfau‐Larrue, M.;
- Haioun, C.
Publication type:
Article
PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 272, doi. 10.1002/hon.83_2630
By:
- Couronné, L.;
- Chaubard, S.;
- Bruneau, J.;
- Laurent, C.;
- Rossignol, J.;
- Suarez, F.;
- Moignet Autrel, A.;
- Clavert, A.;
- Duléry, R.;
- Alexis, M.;
- Lemonnier, F.;
- Noël, R.;
- Tardy, S.;
- Gaulard, P.;
- Fataccioli, V.;
- Kataoka, K.;
- Ghesquières, H.;
- Salles, G.;
- Bachy, E.;
- Hermine, O.
Publication type:
Article
ONE‐YEAR REAL‐LIFE TARGETED NEXT GENERATION SEQUENCING FOR LYMPHOMA DIAGNOSIS: STUDY OF PATIENTS FROM THE FRENCH LYMPHOMA NETWORK IN RHÔNE‐ALPES.
Published in:
Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.2630
By:
- Bommier, C.;
- Mauduit, C.;
- Fontaine, J.;
- Bourbon, E.;
- Sujobert, P.;
- Huet, S.;
- Baseggio, L.;
- Hayette, S.;
- Laurent, C.;
- Bachy, E.;
- Ghesquières, H.;
- Salles, G.;
- Traverse‐Glehen, A.
Publication type:
Article
REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM.
Published in:
Hematological Oncology, 2019, v. 37, p. 301, doi. 10.1002/hon.110_2630
By:
- Thieblemont, C.;
- Le Gouill, S.;
- Di Blasi, R.;
- Cartron, G.;
- Morschhauser, F.;
- Bachy, E.;
- Paillassa, J.;
- Bernard, S.;
- Tessoulin, B.;
- Gastine, T.;
- Fegueux, N.;
- Kanouni, T.;
- Manier, S.;
- Sesques, P.;
- Houot, R.;
- Haouin, C.;
- Tilly, H.;
- Salles, G.
Publication type:
Article
BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 278, doi. 10.1002/hon.89_2630
By:
- Lemonnier, F.;
- Safar, V.;
- Ferchiou, A.;
- Cottereau, A.;
- Bachy, E.;
- Cartron, G.;
- Moles‐Moreau, M.;
- Delmer, A.;
- Bouabdallah, R.;
- Voillat, L.;
- Parrens, M.;
- Casasnovas, O.;
- Cacheux, V.;
- Réguy, C.;
- Tilly, H.;
- Meignan, M.;
- Gaulard, P.;
- Leval, L.;
- Delfau‐Larrue, M.;
- Haioun, C.
Publication type:
Article
PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 272, doi. 10.1002/hon.83_2630
By:
- Couronné, L.;
- Chaubard, S.;
- Bruneau, J.;
- Laurent, C.;
- Rossignol, J.;
- Suarez, F.;
- Moignet Autrel, A.;
- Clavert, A.;
- Duléry, R.;
- Alexis, M.;
- Lemonnier, F.;
- Noël, R.;
- Tardy, S.;
- Gaulard, P.;
- Fataccioli, V.;
- Kataoka, K.;
- Ghesquières, H.;
- Salles, G.;
- Bachy, E.;
- Hermine, O.
Publication type:
Article
ONE‐YEAR REAL‐LIFE TARGETED NEXT GENERATION SEQUENCING FOR LYMPHOMA DIAGNOSIS: STUDY OF PATIENTS FROM THE FRENCH LYMPHOMA NETWORK IN RHÔNE‐ALPES.
Published in:
Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.2630
By:
- Bommier, C.;
- Mauduit, C.;
- Fontaine, J.;
- Bourbon, E.;
- Sujobert, P.;
- Huet, S.;
- Baseggio, L.;
- Hayette, S.;
- Laurent, C.;
- Bachy, E.;
- Ghesquières, H.;
- Salles, G.;
- Traverse‐Glehen, A.
Publication type:
Article
REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM.
Published in:
Hematological Oncology, 2019, v. 37, p. 301, doi. 10.1002/hon.110_2630
By:
- Thieblemont, C.;
- Le Gouill, S.;
- Di Blasi, R.;
- Cartron, G.;
- Morschhauser, F.;
- Bachy, E.;
- Paillassa, J.;
- Bernard, S.;
- Tessoulin, B.;
- Gastine, T.;
- Fegueux, N.;
- Kanouni, T.;
- Manier, S.;
- Sesques, P.;
- Houot, R.;
- Haouin, C.;
- Tilly, H.;
- Salles, G.
Publication type:
Article
Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.
Published in:
2017
By:
- Tixier, F.;
- Ranchon, F.;
- Iltis, A.;
- Vantard, N.;
- Schwiertz, V.;
- Bachy, E.;
- Bouafia‐Sauvy, F.;
- Sarkozy, C.;
- Tournamille, J. F.;
- Gyan, E.;
- Salles, G.;
- Rioufol, C.
Publication type:
journal article
CHARACTERISTICS AND OUTCOMES OF RELAPSED FOLLICULAR LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE RITUXIMAB ERA.
Published in:
Hematological Oncology, 2017, v. 35, p. 220, doi. 10.1002/hon.2438_84
By:
- Sesques, P.;
- Golfier, C.;
- Boursier, J.;
- Bachy, E.;
- Traverse ‐ Glehen, A.;
- Le Gouill, S.;
- Casasnovas, O.;
- Ghesquieres, H.;
- Salles, G.
Publication type:
Article
CAUSE OF DEATH IN FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: A POOLED ANALYSIS OF FRENCH AND US COHORTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 34, doi. 10.1002/hon.2437_15
By:
- Sarkozy, C.;
- Link, B.;
- Ghesquieres, H.;
- Maurer, M.;
- Nicolas ‐ Virelizier, E.;
- Thompson, C.;
- Traverse ‐ Glehen, A.;
- Feldman, A.;
- Allmer, C.;
- Slager, S.;
- Ansell, S.;
- Habermann, T.;
- Bachy, E.;
- Cerhan, J.;
- Salles, G.
Publication type:
Article
INTEGRATIVE ANALYSIS OF FEATURES ASSOCIATED WITH TET2, IDH2, DNMT3 A, AND RHOA MUTATIONS IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: A LYSA STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 165, doi. 10.1002/hon.2438_23
By:
- Lemonnier, F.;
- Safar, V.;
- Cottereau, A.;
- Fataccioli, V.;
- Chaillol, I.;
- Pelletier, R.;
- Letourneau, A.;
- Dupuy, A.;
- Bossard, C.;
- Martin, A.;
- Robe, C.;
- Pelletier, L.;
- Pujals, A.;
- Bachy, E.;
- Delmer, A.;
- Moles Moreau, M.;
- Tilly, H.;
- Parrens, M.;
- Delfau ‐ Larue, M.;
- Missiaglia, E.
Publication type:
Article
Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.
Published in:
Transplant Infectious Disease, 2016, v. 18, n. 4, p. 595, doi. 10.1111/tid.12549
By:
- Barraco, F.;
- Labussière‐Wallet, H.;
- Valour, F.;
- Ducastelle‐Leprêtre, S.;
- Nicolini, F.‐E.;
- Thomas, X.;
- Ferry, T.;
- Dumitrescu, O.;
- Michallet, M.;
- Ader, F.;
- Bachy, E.;
- Balsat, M.;
- Benech, N.;
- Bienvenu, A.‐L.;
- Billaud, G.;
- Biron, F.;
- Boibieux, A.;
- Chidiac, C.;
- Conrad, A.;
- Dupont, D.
Publication type:
Article

Found: 43